Figure 1From: Detecting functional changes with [18F]FAZA in a renal cell carcinoma mouse model following sunitinib therapyCaki-1 tumor growth curves over 40 days. Data from all mice are included; mouse numbers are shown in brackets. Sunitinib (40 mg/kg/day) treatment started on day 13 and finished on day 31. Data are shown as mean ± SEM. **p< 0.01; n.s., not significant.Back to article page